Pharmacy benefit managers shield patients from higher drug prices, but drug makers don’t want you to know that.
September 13, 23Read More
Each plan determines which formulary is best for its unique circumstances.
Lisa Edwards, PharmD, August 02, 23Read More
We are taking a thoughtful and comprehensive approach to assessing biosimilar options that considers several factors.
July 24, 23Read More
By the end of 2023, 11 biosimilars for Humira will be available for patients living with inflammatory conditions, enabling lower costs for a drug class that currently represents nearly 25% of total dr...
June 30, 23Read More
Mark Bini's love for numbers comes in handy in his role as the Head of Growth and Coordinated Care for Evernorth Care Solutions. Learn more about how Mark and his team take a data-driven approach to i...
March 20, 23Read More
Drug formularies are critical to combat the estimated $16 billion wasted each year on low value drugs that do not improve health outcomes.
February 17, 23Read More